These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 22186847)
21. Prothrombin complex concentrate for the urgent reversal of warfarin. Assessment of a standard dosing protocol. Wozniak M; Kruit A; Padmore R; Giulivi A; Bormanis J Transfus Apher Sci; 2012 Jun; 46(3):309-14. PubMed ID: 22503307 [TBL] [Abstract][Full Text] [Related]
22. Prothrombin complex concentrate accelerates international normalized ratio reversal and diminishes the extension of intracranial hemorrhage in geriatric trauma patients. Edavettal M; Rogers A; Rogers F; Horst M; Leng W Am Surg; 2014 Apr; 80(4):372-6. PubMed ID: 24887668 [TBL] [Abstract][Full Text] [Related]
23. Four-factor prothrombin complex concentrate dose response relationship with INR for warfarin reversal. Yohe AS; Livings SE Am J Emerg Med; 2019 Aug; 37(8):1534-1538. PubMed ID: 31130370 [TBL] [Abstract][Full Text] [Related]
25. Experience on using prothrombin complex concentrate in urgent warfarin reversal: an Iranian survey. Haghpanah S; Karimi M; Bordbar M; Kamfiroozi R; Asgharzadeh H Clin Appl Thromb Hemost; 2013 Jun; 19(3):277-81. PubMed ID: 22734101 [TBL] [Abstract][Full Text] [Related]
26. An international, multicenter, prospective study of a prothrombin complex concentrate, Prothromplex Total®, in anticoagulant reversal. Altorjay Á; Szabó É; Boda Z; Kramer L; Ngo LY; Engl W; Firth CL; Ahlstrom ER; Gelmont DM; Pabinger I Thromb Res; 2015 Mar; 135(3):485-91. PubMed ID: 25613927 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of fixed dose 4-factor prothrombin complex concentrate for emergent warfarin reversal. Klein L; Peters J; Miner J; Gorlin J Am J Emerg Med; 2015 Sep; 33(9):1213-8. PubMed ID: 26143315 [TBL] [Abstract][Full Text] [Related]
28. Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. Makris M; Greaves M; Phillips WS; Kitchen S; Rosendaal FR; Preston EF Thromb Haemost; 1997 Mar; 77(3):477-80. PubMed ID: 9065997 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of Warfarin Reversal with 4-Factor Prothrombin Complex Concentrate Compared to 3-Factor Prothrombin Complex Concentrate at a Tertiary Academic Medical Center. Al-Majzoub O; Rybak E; Reardon DP; Krause P; Connors JM J Emerg Med; 2016 Jan; 50(1):7-13. PubMed ID: 26433428 [TBL] [Abstract][Full Text] [Related]
30. Optimizing warfarin reversal--an ex vivo study. Gatt A; Riddell A; van Veen JJ; Kitchen S; Tuddenham EG; Makris M J Thromb Haemost; 2009 Jul; 7(7):1123-7. PubMed ID: 19575759 [TBL] [Abstract][Full Text] [Related]
31. Less Is More: Low-dose Prothrombin Complex Concentrate Effective in Acute Care Surgery Patients. Quick JA; Meyer JM; Coughenour JP; Barnes SL Am Surg; 2015 Jun; 81(6):646-50. PubMed ID: 26031281 [TBL] [Abstract][Full Text] [Related]
33. Audit of warfarin reversal using a new Octaplex reduced dose protocol. Hirri HM; Green PJ Transfus Apher Sci; 2014 Oct; 51(2):141-5. PubMed ID: 25241119 [TBL] [Abstract][Full Text] [Related]
34. Comparison of the capacities of two prothrombin complex concentrates to restore thrombin generation in plasma from orally anticoagulated patients: an in vitro study. Dargaud Y; Desmurs-Clavel H; Marin S; Bordet JC; Poplavsky JL; Negrier C J Thromb Haemost; 2008 Jun; 6(6):962-8. PubMed ID: 18373620 [TBL] [Abstract][Full Text] [Related]
35. [Use of warfarin and low range INR in the prevention of recurrent venous thrombosis]. Quintero J; Torres E; Diez-Ewald M; Arteaga-Vizcaíno M; Vizcaíno G; León M; Rodríguez Z; Fernández N Invest Clin; 2011 Sep; 52(3):230-8. PubMed ID: 21950194 [TBL] [Abstract][Full Text] [Related]
37. Low-dose Prothrombin Complex Concentrate for Warfarin-Associated Intracranial Hemorrhage with INR Less Than 2.0. Zemrak WR; Smith KE; Rolfe SS; May T; Trowbridge RL; Hayes TL; Grindlinger GA; Seder DB Neurocrit Care; 2017 Dec; 27(3):334-340. PubMed ID: 28660341 [TBL] [Abstract][Full Text] [Related]
38. Low-dose compared to manufacturer-recommended dose four-factor prothrombin complex concentrate for acute warfarin reversal. Zemrak W; Manuel F; Smith KE; Rolfe S; Hayes T; Trowbridge RL; Carlone B; Seder D J Thromb Thrombolysis; 2019 Feb; 47(2):263-271. PubMed ID: 30443817 [TBL] [Abstract][Full Text] [Related]
39. Warfarin-reversal: results of a phase III study with pasteurised, nanofiltrated prothrombin complex concentrate. Pabinger-Fasching I Thromb Res; 2008; 122 Suppl 2():S19-22. PubMed ID: 18549908 [TBL] [Abstract][Full Text] [Related]
40. Laboratory assessment of warfarin reversal with global coagulation tests versus international normalized ratio in patients with intracranial bleeding. Voils SA; Martin EJ; Mohammed BM; Bayrlee A; Brophy DF Blood Coagul Fibrinolysis; 2015 Jun; 26(4):443-7. PubMed ID: 25699612 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]